Is HER2/neu a predictor for invasive recurrence in DCIS.

被引：0
|
作者：
Nofech-Mozes, S.
Spayne, J.
Kahn, H. J.
Rakovitch, E.
Arun, S.
Pignol, J-P
Lickley, L.
Paszat, L.
Hanna, W.
机构：
[1] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada
[2] Toronto Sunnybrook Reg Canc Ctr, Toronto, ON, Canada
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2006年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S77 / S77
页数：1
相关论文
共 50 条
  • [1] DCIS and HER2/neu
    Tulusan, AH
    ONKOLOGIE, 2002, 25 : 11 - 12
  • [2] Relationship between Pathological Features, Her2 Protein Expression, and HER2 and CEP17 Copy Numbers in DCIS.
    Lambein, K.
    Van Bockstal, M.
    Praet, M.
    Denys, H.
    Braems, G.
    Nuyts, A.
    Cocquyt, V.
    Pauweis, P.
    Van Den Broecke, R.
    Libbrecht, L.
    CANCER RESEARCH, 2011, 71
  • [3] Factors affecting recurrence risk in her2 positive dcis
    Di Cesare, P.
    Pavesi, L.
    Villani, L.
    Frascaroli, M.
    ANNALS OF ONCOLOGY, 2015, 26 : 23 - 23
  • [4] HER2/neu in the management of invasive breast cancer
    Meric, F
    Hung, MC
    Hortobagyi, GN
    Hunt, KK
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2002, 194 (04) : 488 - 501
  • [5] Reduced/Absent PTEN Expression Is More Common in HER2 Non-Amplified DCIS.
    Sakr, R.
    Chandarlapaty, S.
    Wynveen, C.
    Barbashina, V
    Arroyo, C.
    Morrogh, M.
    Heguy, A.
    Olvera, N.
    Rosen, A.
    Morrow, M.
    King, T.
    CANCER RESEARCH, 2009, 69 (24) : 873S - 873S
  • [6] The concordance of estrogen and progesterone receptor status (ER-PR) and HER2/neu expression in DCIS coexistent with micro-invasive and invasive carcinoma
    Ali-Fehmi, R.
    Nahleh, Z. A.
    Ahmed, Q.
    Sethi, S.
    Sakr, W.
    Hussein, Y.
    Ibrahim, M.
    Albashiti, B.
    Hayek, K.
    Bandyopadhyay, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [7] HER2/neu Expression: A Predictor for Differentiation and Survival in Children With Wilms Tumor
    Ragab, Seham M.
    Samaka, Rehab M.
    Shams, Tahany M.
    PATHOLOGY & ONCOLOGY RESEARCH, 2010, 16 (01) : 61 - 67
  • [8] Incidence and prediction of tumour recurrence of Her2/neu overexpression in bladder cancer
    不详
    EUROPEAN UROLOGY SUPPLEMENTS, 2005, 4 (03) : 86 - 86
  • [9] Changing Frequency of Equivocal HER2/Neu Scores and Factors Predictive of Negative HER2/Neu Fluorescent In-Situ Hybridization in Invasive Carcinomas of the Breast
    Boulos, F. I.
    Massad, C. J. Youssef
    Fedda, F. A.
    Farra, C. G.
    Aldin, E. M. Saad
    Doumiati, H.
    Tawil, A. N.
    Tfayli, A.
    LABORATORY INVESTIGATION, 2012, 92 : 26A - 27A
  • [10] Clinicopathological significance of HER2/neu genetic heterogeneity in HER2/neu non-amplified invasive breast carcinomas and its concurrent axillary metastasis
    Shafi, Hedyeh
    Astvatsaturyan, Kristine
    Chung, Fai
    Mirocha, James
    Schmidt, Michael
    Bose, Shikha
    JOURNAL OF CLINICAL PATHOLOGY, 2013, 66 (08) : 649 - 654
12345